DocGo Inc. provided earnings guidance for the year 2024. The revenue expectation for 2024 base businesses going forward, medical transportation and non-migrant mobile health is $280 million to $300 million, in line with previous expectations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -0.68% | -3.93% | -47.58% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.58% | 298M | |
-4.11% | 2.98B | |
-.--% | 1.93B | |
+23.65% | 1.86B | |
-11.21% | 461M | |
-19.40% | 174M | |
-16.45% | 131M | |
+1.92% | 67.77M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings Guidance for the Year 2024